Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired ...
The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’  therapy for a rare form of obesity ​caused ...
Scientists say a record-smashing March heat wave in the U.S. Southwest shows climate change is already driving more dangerous weather extremes. World Weather Attribution said Friday that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results